Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:39 PM
Ignite Modification Date:
2025-12-24 @ 1:39 PM
NCT ID:
NCT04803695
Eligibility Criteria:
Inclusion Criteria:
* BE criteria (with and without COPD)
* Isolation of PA in sputum in the stable phase. \* A prospective screening of BQ patients in outpatient consultations will be conducted to prospectively detect those with isolation of PA in the sputum.
Exclusion Criteria:
* CF
* Immunosuppression (primary and secondary, with the exception of cases of IgG deficiency in stable substitution treatment)
* Sarcoidosis
* Tuberculosis, active infection by nontuberculous mycobacteria
* Diffuse interstitial lung disease
* Altered state of consciousness or disability to understand the study and perform the tests provided by it, involving the patient in another intervention study (clinical trials).
* Patients with CF are excluded because the role of PA biofilms in CF has been extensively studied, as argued in the background of the present proposal and the selected literature. It is also a totally different disease from the one we intend to study, with patients of much younger ages. Finally, this is a very vulnerable population in which it would be very difficult to obtain all the samples sequentially.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04803695
Study Brief:
Protocol Section:
NCT04803695